Laman UtamaABCL • NASDAQ
add
AbCellera Biologics Inc
$2.76
Selepas Waktu Dagangan:(0.36%)-0.0100
$2.75
Tutup: 22 Nov, 8:00:00 PTG GMT-5 · USD · NASDAQ · Penafian
Tutup sebelumnya
$2.72
Julat hari
$2.71 - $2.83
Julat tahun
$2.34 - $6.05
Permodalan pasaran
815.21J USD
Bilangan Purata
2.37J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Hasil | 6.51J | -1.39% |
Perbelanjaan pengendalian | 59.20J | 151.15% |
Pendapatan bersih | -51.11J | -78.63% |
Margin untung bersih | -785.42 | -81.16% |
Pendapatan bagi setiap syer | -0.17 | -70.00% |
EBITDA | -56.74J | -15.44% |
Kadar cukai berkesan | 18.40% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 643.14J | -18.16% |
Jumlah aset | 1.39B | -7.89% |
Jumlah liabiliti | 314.73J | -4.46% |
Jumlah ekuiti | 1.08B | — |
Syer tertunggak | 295.37J | — |
Harga kepada buku | 0.75 | — |
Pulangan pada aset | -16.69% | — |
Pulangan pada modal | -20.08% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -51.11J | -78.63% |
Tunai daripada operasi | -28.88J | -27,147.17% |
Tunai daripada pelaburan | 3.70J | 128.92% |
Tunai daripada pembiayaan | 3.14J | -52.56% |
Perubahan bersih dalam tunai | -21.67J | -195.86% |
Aliran tunai bebas | -10.48J | 72.64% |
Perihal
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Diasaskan
2012
Ibu pejabat
Tapak web
Pekerja
586
